Brief: Biosyent Reports Fourth Quarter Results
21/03/2023 20:34
March 21 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT RELEASES FINANCIAL RESULTS FOR FOURTH QUARTER AND
FULL
YEAR 2022
* BIOSYENT INC-Q4 2022 FULLY DILUTED EPS OF $0.09
Source text for Eikon: ID:nGNX6Y4dYV
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid